CME Group Inc. - (CME): Price and Financial Metrics
CME Group Inc. - (CME)
Today's Latest Price: $150.72 USD
Updated Oct 30 4:00pm
Add CME to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 5 in Financial Marketplaces
See all "A" rated Strong Buy stocks
CME Stock Summary
- With a market capitalization of $54,051,967,687, Cme Group Inc has a greater market value than 96.53% of US stocks.
- The ratio of debt to operating expenses for Cme Group Inc is higher than it is for about 98.01% of US stocks.
- In terms of volatility of its share price, CME is more volatile than merely 8.82% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to Cme Group Inc are BNS, WBK, GS, SC, and GM.
- CME's SEC filings can be seen here. And to visit Cme Group Inc's official web site, go to www.cmegroup.com.
CME Stock Price Chart Interactive Chart >
CME Price/Volume Stats
| Current price | $150.72 | 52-week high | $225.36 |
| Prev. close | $149.99 | 52-week low | $131.80 |
| Day low | $147.80 | Volume | 1,947,800 |
| Day high | $150.87 | Avg. volume | 1,958,375 |
| 50-day MA | $167.28 | Dividend yield | 2.26% |
| 200-day MA | $178.84 | Market Cap | 54.05B |
CME Group Inc. - (CME) Company Bio
CME Group operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products for trading and/or clearing across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. The company was founded in 1898 and is based in Chicago, Illinois.
CME Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $150.72 | $270.86 | 81% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Cme Group Inc. To summarize, we found that Cme Group Inc ranked in the 59th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. In terms of the factors that were most noteworthy in this DCF analysis for CME, they are:
- 39% of the company's capital comes from equity, which is greater than only 20.01% of stocks in our cash flow based forecasting set.
- CME's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than merely 0.52% of tickers in our DCF set.
- The weighted average cost of capital for the company is 6. This value is greater than only 0.56% stocks in the Financial Services sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 78% |
| 1% | 79% |
| 2% | 81% |
| 3% | 83% |
| 4% | 85% |
| 5% | 86% |
CB, GHL, AMG, WRB, and AFL can be thought of as valuation peers to CME, in the sense that they are in the Financial Services sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...